Fischer Medical Ventures Ltd (Fischer MV), a trailblazer in the healthcare industry, has announced its investment and collaboration with Bio Angle Vacs Sdn Bhd (BAV), a leading biotechnology company in Malaysia. BAV is renowned for developing, manufacturing, and distributing vaccines for livestock and aquaculture, focusing on health and disease prevention on a global scale.
To date, BAV has secured an impressive US$ 83 million in annual sales contracts from countries such as China, Nigeria, Kenya, Chad, Uganda, Uzbekistan, and Indonesia, thanks to its innovative and highly sought-after animal vaccines.
Fischer MV, formerly known as Fischer Chemic Ltd, is celebrated for its affordable and high-quality medical diagnostic and imaging technologies. The company leverages cutting-edge innovations and AI-powered software solutions in healthcare. Notably, Fischer MV was the first company to indigenously manufacture advanced Magnetic Resonance Imaging (MRI) systems in India and boasts a diverse portfolio of breakthrough diagnostic solutions and AI healthcare platforms.
Founded in 2013, BAV has revolutionized the animal vaccination industry with its groundbreaking delivery methods that prioritize quality, safety, and efficacy. Its flagship innovation, the Spray Technology Vaccine (STVAC), was developed and patented by BAV’s founder, Prof. Mohd Zamri Saad, in collaboration with scientists from the Faculty of Veterinary Medicine at Universiti Putra Malaysia (UPM).
Ravindran Govindan, Executive Chairman & MD of Fischer MV, expressed confidence in the collaboration: “This partnership with BAV is our commitment to food security, starting from India with its 2nd largest sheep & goat population of about 223 million. With Fischer MV’s expertise in MedTech solutions, robust resources, and strategic network, we aim to bring BAV’s groundbreaking, cost-effective animal vaccines and products to the global market to improve food safety.”
Noor Shazreena Ishak, CEO of BAV, shared her enthusiasm: “With the growing demand for preventive healthcare in the animal world, we are dedicated to offering easy, cost-effective, and trustworthy solutions. Through this collaboration with Fischer MV, we will have stronger scientific, technological, and marketing support to meet the global demand for quality and affordable animal vaccines, ultimately reducing the burden of animal diseases worldwide.”
This partnership represents a pivotal moment for Fischer MV to advance its mission to strengthen global food security and health. Fischer MV is committed to ensuring the world’s food supply remains safe and resilient, directly contributing to better healthcare and healthier lives for people everywhere.
